We are live on ! Find out more
Ray Dalio

Ray Dalio Bridgewater Associates

AUM $22.4B
1-Year Est. Return 34.48%
 

Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.

This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+34.48%
3 Year Est. Return
+84.29%
5 Year Est. Return
+89.92%
10 Year Est. Return
+230.06%
AUM
$9.79B
AUM Growth
-$1.59B
Cap. Flow
-$2.32B
Cap. Flow %
-23.7%
Top 10 Hldgs %
67.42%
Holding
589
New
256
Increased
103
Reduced
104
Closed
118

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$83.3M
2
BAC icon
Bank of America
BAC
+$60.7M
3
WFC icon
Wells Fargo
WFC
+$46.3M
4
C icon
Citigroup
C
+$33.4M
5
USB icon
US Bancorp
USB
+$18.8M

Sector Composition

Rank Sector Weight
1 Financials 6.62%
2 Consumer Discretionary 3.62%
3 Industrials 2.16%
4 Materials 1.56%
5 Technology 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBM icon
526
IBM
IBM
$224B
-24,672
Closed -$3.43M
IDXX icon
527
Idexx Laboratories
IDXX
$46.2B
-3,646
Closed -$991K
INTC icon
528
Intel
INTC
$513B
-215,421
Closed -$11.1M
IPG
529
DELISTED
Interpublic Group of Companies
IPG
-960,978
Closed -$20.7M
IRM icon
530
Iron Mountain
IRM
$36.1B
-48,484
Closed -$1.57M
ISRG icon
531
Intuitive Surgical
ISRG
$134B
-33,630
Closed -$6.05M
IT icon
532
Gartner
IT
$11.7B
-2,159
Closed -$309K
JKHY icon
533
Jack Henry & Associates
JKHY
$11.1B
-3,328
Closed -$486K
KO icon
534
Coca-Cola
KO
$375B
-39,025
Closed -$2.13M
KR icon
535
Kroger
KR
$34.8B
-69,154
Closed -$1.78M
KSS icon
536
Kohl's
KSS
$2.19B
-654,710
Closed -$32.5M
LBTYA icon
537
Liberty Global Class A
LBTYA
$3.6B
-199,008
Closed -$4.92M
LLY icon
538
Eli Lilly
LLY
$1.06T
-8,135
Closed -$910K
LMT icon
539
Lockheed Martin
LMT
$136B
-3,986
Closed -$1.55M
MCK icon
540
McKesson
MCK
$101B
-168,575
Closed -$23M
META icon
541
Meta Platforms (Facebook)
META
$1.51T
-29,811
Closed -$5.31M
MMM icon
542
3M
MMM
$94.3B
-33,312
Closed -$4.58M
MNST icon
543
Monster Beverage
MNST
$88.4B
-241,714
Closed -$7.02M
MO icon
544
Altria Group
MO
$114B
-344,301
Closed -$14.1M
MORN icon
545
Morningstar
MORN
$7.53B
-2,297
Closed -$336K
MPC icon
546
Marathon Petroleum
MPC
$83.7B
-176,371
Closed -$10.7M
MRK icon
547
Merck
MRK
$318B
-8,270
Closed -$664K
NLY icon
548
Annaly Capital Management
NLY
$17.4B
-37,093
Closed -$1.31M
NOC icon
549
Northrop Grumman
NOC
$81.2B
-20,047
Closed -$7.51M
NRG icon
550
NRG Energy
NRG
$24.8B
-545,769
Closed -$21.6M

Similar funds

Ray Dalio's Q4 2019 Portfolio in Review

As of Q4 2019, Ray Dalio held 589 positions worth $9.79B, down 14% from $11.4B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Ray Dalio withdrew a net $2.32B in Q4 2019, closing 118 positions and reducing 104 holdings. Its most notable exit was Biogen, an estimated $55.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 6.6% of assets, up from 3.2% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Ray Dalio opened a new position in JPMorgan Chase worth $90.5M.

  • Ray Dalio's largest Q4 2019 buy was JPMorgan Chase: 649,376 shares worth $90.5M.
  • Ray Dalio added most to iShares MSCI Taiwan ETF in Q4 2019, an estimated $16.2M increase.
  • Ray Dalio's biggest Q4 2019 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $535M.
  • Ray Dalio fully exited Biogen in Q4 2019, selling an estimated $55.3M.
  • Ray Dalio's ten largest holdings make up 67% of its $9.79B portfolio in Q4 2019.
  • Ray Dalio opened 256 new positions and closed 118 in Q4 2019.
  • Ray Dalio's portfolio value fell 14% quarter-over-quarter to $9.79B.

Based on Bridgewater Associates's 13F filing for Q4 2019, filed 13 Feb 2020.